| Product Code: ETC9678166 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Antisense and RNAi Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Antisense and RNAi Therapeutics Market - Industry Life Cycle |
3.4 Thailand Antisense and RNAi Therapeutics Market - Porter's Five Forces |
3.5 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Antisense and RNAi Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Thailand |
4.2.2 Growing RD investments in antisense and RNAi therapeutics in the country |
4.2.3 Favorable regulatory environment supporting the development and commercialization of such therapeutics |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of antisense and RNAi therapeutics among healthcare professionals and patients in Thailand |
4.3.2 High costs associated with the development and production of these advanced therapies |
4.3.3 Challenges in securing reimbursement and insurance coverage for antisense and RNAi treatments |
5 Thailand Antisense and RNAi Therapeutics Market Trends |
6 Thailand Antisense and RNAi Therapeutics Market, By Types |
6.1 Thailand Antisense and RNAi Therapeutics Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Cardiovascular Diseases (CVDs), 2021- 2031F |
6.1.5 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Respiratory Disorders, 2021- 2031F |
6.1.6 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.1.7 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.8 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Antisense and RNAi Therapeutics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By RNA Interference, 2021- 2031F |
6.2.3 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Antisense RNA, 2021- 2031F |
6.3 Thailand Antisense and RNAi Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Pulmonary Delivery, 2021- 2031F |
6.3.3 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Intravenous Injections, 2021- 2031F |
6.3.4 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Intra-Dermal, 2021- 2031F |
6.3.5 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Intraperitoneal, 2021- 2031F |
6.3.6 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.7 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Antisense and RNAi Therapeutics Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Antisense and RNAi Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Thailand Antisense and RNAi Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Antisense and RNAi Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand Antisense and RNAi Therapeutics Market Export to Major Countries |
7.2 Thailand Antisense and RNAi Therapeutics Market Imports from Major Countries |
8 Thailand Antisense and RNAi Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials involving antisense and RNAi therapeutics conducted in Thailand |
8.2 Adoption rate of antisense and RNAi therapeutics by healthcare facilities in the country |
8.3 Investment trends in research and development of new antisense and RNAi therapies in Thailand |
9 Thailand Antisense and RNAi Therapeutics Market - Opportunity Assessment |
9.1 Thailand Antisense and RNAi Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Thailand Antisense and RNAi Therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Thailand Antisense and RNAi Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Antisense and RNAi Therapeutics Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Thailand Antisense and RNAi Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Antisense and RNAi Therapeutics Market - Competitive Landscape |
10.1 Thailand Antisense and RNAi Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Antisense and RNAi Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here